Ponatinib in Ph+ ALL and MRD Negativity: Ibrahim Aldoss, MD

Retrieved on: 2025-06-01 17:08:19

Tags for this article:

Click the tags to see associated articles and topics

Ponatinib in Ph+ ALL and MRD Negativity: Ibrahim Aldoss, MD. View article details on hiswai:

Excerpt

What do the long-term event-free survival results look like for PhALLCON? ... care. Moreover, long-term data on potential harms are lacking ...

Article found on: www.ajmc.com